# Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy

> **NCT02559440** · PHASE4 · COMPLETED · sponsor: **Guangzhou Women and Children's Medical Center** · enrollment: 240 (actual)

## Conditions studied

- Adenoidal Hypertrophy

## Interventions

- **DRUG:** mometasone furoate
- **DRUG:** Placebo
- **DRUG:** Oxymetazoline + Placebo
- **DRUG:** Placebo + placebo
- **DRUG:** mometasone furoate + Placebo
- **DRUG:** mometasone furoate + Oxymetazoline

## Key facts

- **NCT ID:** NCT02559440
- **Lead sponsor:** Guangzhou Women and Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-08
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02559440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02559440, "Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02559440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*